Managing a safe laboratory for studying infectious diseases
BSL3 management and practice of infectious disease research at HTRL
['FUNDING_OTHER'] · UNIVERSITY OF CHICAGO · NIH-10910202
This study is all about keeping a special lab safe and running smoothly so that scientists can research dangerous germs, like those that could come from bioterrorism or new viruses, to help us better understand and fight infectious diseases that can affect our health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10910202 on ClinicalTrials.gov |
What this research studies
This research focuses on maintaining and managing a Biosafety Level 3 (BSL3) laboratory dedicated to studying infectious diseases, particularly those that could arise from bioterrorism or emerging pathogens like the novel coronavirus. The project involves training professionals in biosafety practices and ensuring the safe operation of the laboratory, which is crucial for conducting research on disease-causing microbes and understanding how they affect human health. By leveraging existing expertise and resources, the laboratory aims to enhance our ability to detect and respond to infectious disease threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in infectious disease management, public health professionals, and researchers in microbiology.
Not a fit: Patients with non-infectious diseases or those not involved in research or public health may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could improve our preparedness and response to infectious disease outbreaks, ultimately protecting public health.
How similar studies have performed: Previous research in similar BSL3 facilities has shown success in advancing our understanding of infectious diseases and improving biosafety practices.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MISSIAKAS, DOMINIQUE M. — UNIVERSITY OF CHICAGO
- Study coordinator: MISSIAKAS, DOMINIQUE M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.